Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors.

Direct thrombin inhibitors (DTIs), such as bivalirudin and dabigatran, have maintained steady inpatient and outpatient use as substitutes for heparin and warfarin, respectively, because of their high bioavailability and relatively safe "ontherapy" range. Current clinical methods lack the capacity to...

Full description

Bibliographic Details
Published in:Journal of Extra-Corporeal Technology Vol. 51; no. 1; pp. 29 - 38
Main Authors: Alouidor, Benjamin, Sweeney, Robin E., Tat, Trinny, Wong, Raymond K., Jeong-Yeol Yoon
Format: Journal Article
Published: AMSECT Mar2019
Online Access:View this record in EBSCOhost